This may indicate that the liver microenvironment including LX‐2 cells plays a role in reducing the efficacy of BET inhibitors and co‐inhibition of FGFRs by AZD4547 treatment significantly suppresses tumor growth compared to PLX51107‐treated mice. The gene discussed is DNER; the disease is neoplasm.